改善皮肤软组织感染住院患者的经验性抗生素选择:INSPIRE 3 皮肤软组织随机临床试验
INSPIRE 3 是一项纳入92家医院的整群随机临床试验,评估在非ICU的皮肤软组织感染(SSTI)住院成人中,计算机化医嘱录入(CPOE)提示(当多药耐药菌SSTI绝对风险估计低于10%时推荐标准谱抗生素)联合反馈与教育,对比常规抗菌药物管理对经验性抗生素选择的影响。共纳入118 562例患者,基线期57 837例、干预期60 725例。CPOE组经验性广谱抗生素治疗天数从基线496.2降至干预359.1/1000经验性天,常规管理组从511.5降至488.7(率比0.72,95%CI 0.67-0.79,P<.001)。CPOE组住院时间6.4(3.8)天 vs 常规管理组6.5(3.8)天,ICU转入天数6.3(3.1) vs 6.3(3.2)天,无劣效性证据。
要点
- 在92家医院非ICU的SSTI住院成人中,CPOE提示联合反馈与教育使经验性广谱抗生素治疗天数率比为0.72(95%CI 0.67-0.79,P<.001)。
- CPOE组接受任何经验性广谱抗生素比例从基线55.4%(15 650/28 242)降至干预43.0%(12 647/29 388),常规管理组从57.0%(16 855/29 595)降至56.0%(17 534/31 337)。
- CPOE组住院时间6.4(3.8)天 vs 常规管理组6.5(3.8)天,ICU转入天数6.3(3.1) vs 6.3(3.2)天,无劣效性证据。
- CPOE提示在估计多药耐药菌SSTI绝对风险低于10%时推荐标准谱抗生素,适用于非ICU成人SSTI经验性治疗期(住院前3天)。
适用人群与场景
- 18岁及以上、因皮肤软组织感染(SSTI)住院并在非ICU场所接受经验性抗生素治疗的成人。
- 数据收集时间为2019年1月至2023年12月。
诊断标准与关键阈值
- CPOE提示在估计多药耐药菌SSTI绝对风险低于10%时推荐标准谱抗生素。
处置流程与药物剂量
- CPOE提示对经验性治疗期(住院前3天)被处方广谱抗生素、且估计多药耐药菌SSTI绝对风险低于10%的患者推荐标准谱抗生素,并联合反馈与教育。
研究设计与关键结果
- 整群随机临床试验,纳入92家医院118 562例SSTI住院患者,基线期57 837例、干预期60 725例;67 033例(56.7%)为男性,平均(SD)年龄58.0(17.5)岁。
- 主要终点:针对假单胞菌和/或多药耐药革兰阴性菌的经验性广谱抗生素治疗天数/1000经验性天,常规管理组基线511.5、干预期488.7,CPOE组基线496.2、干预期359.1(率比0.72,95%CI 0.67-0.79,P<.001)。
- 接受任何经验性广谱抗生素比例:常规管理组基线57.0%(16 855/29 595)、干预期56.0%(17 534/31 337);CPOE组基线55.4%(15 650/28 242)、干预期43.0%(12 647/29 388)。
- 安全性:平均(SD)住院时间常规管理组6.5(3.8)天 vs CPOE组6.4(3.8)天;ICU转入天数常规管理组6.3(3.2)天 vs CPOE组6.3(3.1)天,无劣效性证据。
证据类型、等级与局限
- 证据类型:整群随机临床试验(INSPIRE 3),临床试验注册号NCT05423756。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对非ICU的SSTI住院成人,在估计多药耐药菌SSTI绝对风险低于10%时,CPOE提示推荐标准谱经验性抗生素可显著减少广谱抗生素使用,且不增加ICU转入或住院时间。
- 该策略适用于非ICU成人SSTI经验性治疗期(住院前3天),不适用于ICU患者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Empiric extended-spectrum antibiotics are routinely prescribed for patients hospitalized with skin and soft tissue infections (SSTIs) despite low likelihoods of infection with multidrug-resistant organisms (MDROs).
OBJECTIVE: To evaluate whether computerized provider order entry (CPOE) prompts presenting patient-specific and pathogen-specific MDRO infection risk estimates could reduce empiric extended-spectrum antibiotics for noncritically ill patients admitted with SSTI.
DESIGN, SETTING, AND PARTICIPANTS: This cluster randomized clinical trial included 92 hospitals and assessed the effect of an antibiotic stewardship bundle that included CPOE prompts vs routine stewardship on antibiotic selection during the first 3 hospital days (empiric period) in noncritically ill adults hospitalized with SSTI. The trial population included adults 18 years and older treated with empiric antibiotics for SSTI in non-intensive care unit (ICU) settings. Data were collected from January 2019 to December 2023.
INTERVENTIONS: CPOE prompts recommending standard-spectrum antibiotics in patients prescribed extended-spectrum antibiotics during the empiric period when absolute risk of MDRO SSTI was estimated to be less than 10%, coupled with feedback and education.
MAIN OUTCOMES AND MEASURES: The primary outcome was empiric extended-spectrum antibiotic days of therapy (summed number of different extended-spectrum antibiotics targeting Pseudomonas and/or MDR gram-negative bacteria received per patient each calendar day). The secondary outcome was antipseudomonal days of therapy. Safety outcomes included days to ICU transfer and hospital length of stay. Outcomes compared differences between baseline and intervention periods across strategies.
RESULTS: Among 118 562 patients admitted with SSTI at 92 hospitals, 67 033 (56.7%) were male and the mean (SD) age was 58.0 (17.5) years. A total of 57 837 patients were included in the baseline period and 60 725 in the intervention period. Receipt of any empiric extended-spectrum antibiotic during the baseline and intervention periods was 57.0% (16 855 of 29 595) and 56.0% (17 534 of 31 337), respectively, for the routine stewardship group compared with 55.4% (15 650 of 28 242) and 43.0% (12 647 of 29 388), respectively, for the CPOE group. Empiric extended-spectrum days of therapy per 1000 empiric days targeting Pseudomonas and/or MDR gram-negative pathogens was 511.5 during the baseline period and 488.7 during the intervention period in the routine stewardship group and was 496.2 and 359.1, respectively, in the CPOE bundle group (rate ratio, 0.72; 95% CI, 0.67-0.79; P < .001). There was no evidence of inferiority in the CPOE bundle group for mean (SD) hospital length of stay (routine stewardship, 6.5 [3.8] days; CPOE bundle, 6.4 [3.8] days) and days to ICU transfer (routine stewardship, 6.3 [3.2] days; CPOE bundle, 6.3 [3.1] days).
CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, CPOE prompts recommending standard-spectrum empiric antibiotics for low-risk patients hospitalized with SSTI coupled with education and feedback significantly reduced use of extended-spectrum antibiotics without increasing admissions to ICUs or hospital length of stay.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05423756.
参考来源
- Gohil SK, Septimus E, Kleinman K, et al. Improving Empiric Antibiotic Selection for Patients Hospitalized With Skin and Soft Tissue Infection: The INSPIRE 3 Skin and Soft Tissue Randomized Clinical Trial. JAMA Intern Med. 2025. PMID: 40208610. doi:10.1001/jamainternmed.2025.0887
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。